Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20–a very high-risk subtype in B-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20–a very high-risk subtype in B-cell acute lymphoblastic leukemia

Published:2022-09-02 Issue:12 Volume:57 Page:1751-1757
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tang Bingqing,Cai Zihong,Wang Zhixiang,Lin Dainan,He Xianjun,Li Qiuli,Liang Xiaojie,Huang Kangyu,Zhou Xuan,Lin Ren^ORCID,Xu Na,Fan Zhiping,Huang Fen,Sun Jing,Liu Xiaoli,Liu Qifa^ORCID,Zhou Hongsheng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01797-1.pdf

Reference30 articles.

1. Zinngrebe J, Schlichtig F, Kraus JM, Meyer M, Boldrin E, Kestler HA, et al. Biomarker profile for prediction of response to SMAC mimetic monotherapy in pediatric precursor B-cell acute lymphoblastic leukemia. Int J Cancer. 2020;146:3219–31. https://doi.org/10.1002/ijc.32799.

2. Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there. Blood. 2012;120:1165–74. https://doi.org/10.1182/blood-2012-05-378943.

3. Stock W, Luger SM, Advani AS, Yin J, Harvey RC, Mullighan CG, et al. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood. 2019;133:1548–59. https://doi.org/10.1182/blood-2018-10-881961.

4. Lazaryan A, Dolan M, Zhang MJ, Wang HL, Kharfan-Dabaja MA, Marks DI, et al. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. 2020;105:1329–38. https://doi.org/10.3324/haematol.2019.220756.

5. Bender C, Maese L, Carter-Febres M, Verma A. Clinical utility of pegaspargase in children, adolescents and young adult patients with acute lymphoblastic leukemia: a review. Blood Lymphat Cancer. 2021;11:25–40. https://doi.org/10.2147/BLCTT.S245210.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome‐like acute lymphoblastic leukemia;HemaSphere;2024-05

2. STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B‐cell acute lymphoblastic leukaemia;British Journal of Haematology;2024-04-19

3. Superior Survival with Allogeneic Hematopoietic Stem Cell Transplantation versus Chemotherapy for High-Risk Adult Acute Lymphoblastic Leukemia in PDT-ALL-2016 Pediatric-Inspired Cohort;2024-03-07

4. PASS‐ALL study of paediatric‐inspired versus adult chemotherapy regimens on survival of high‐risk Philadelphia‐negative B‐cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation;British Journal of Haematology;2023-12-05

5. Prognostic impact of TP53 mutations in adult acute lymphoblastic leukemia treated with a pediatric-type regimen;Leukemia & Lymphoma;2023-11-08